BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Giulia Roda, Siew Chien Ng, Paulo Gustavo Kotze, Marjorie Argollo, Remo Panaccione, Antonino Spinelli, Arthur Kaser, Laurent Peyrin-Biroulet, Silvio Danese. Crohn’s diseaseNature Reviews Disease Primers 2020; 6(1) doi: 10.1038/s41572-020-0156-2
2
Ondrej Hradsky, Ivana Copova, Kristyna Zarubova, Jiri Nevoral, Jiri Bronsky. Time to Relapse in Children with Crohn’s Disease Treated with Azathioprine and Nutritional Therapy or CorticosteroidsDigestive Diseases and Sciences 2016; 61(7): 2041 doi: 10.1007/s10620-016-4103-8
3
Elisa Liverani, Eleonora Scaioli, Richard John Digby, Matteo Bellanova, Andrea Belluzzi. How to predict clinical relapse in inflammatory bowel disease patientsWorld Journal of Gastroenterology 2016; 22(3): 1017-1033 doi: 10.3748/wjg.v22.i3.1017
4
Simon P. Borg-Bartolo, Ray Kiran Boyapati, Jack Satsangi, Rahul Kalla. Precision medicine in inflammatory bowel disease: concept, progress and challengesF1000Research 2020; 9: 54 doi: 10.12688/f1000research.20928.1
5
Peter Brown, Tanya Clark, Grace Dowson, Lisa Warren, John Hamlin, Mark Hull, Venkataraman Subramanian. Relationship of Body Mass Index to Clinical Outcomes after Infliximab Therapy in Patients with Crohn’s DiseaseJournal of Crohn's and Colitis 2016; 10(10): 1144 doi: 10.1093/ecco-jcc/jjw079
6
Guillaume Bouguen, Barrett G. Levesque, Brian G. Feagan, Arthur Kavanaugh, Laurent Peyrin–Biroulet, Jean–Frederic Colombel, Stephen B. Hanauer, William J. Sandborn. Treat to Target: A Proposed New Paradigm for the Management of Crohn's DiseaseClinical Gastroenterology and Hepatology 2015; 13(6): 1042 doi: 10.1016/j.cgh.2013.09.006
7
Cláudia Camila Dias, Pedro Pereira Rodrigues, Samuel Fernandes, Francisco Portela, Paula Ministro, Diana Martins, Paula Sousa, Paula Lago, Isadora Rosa, Luis Correia, Paula Moura Santos, Fernando Magro, Francesco Pappalardo. The risk of disabling, surgery and reoperation in Crohn’s disease – A decision tree-based approach to prognosisPLOS ONE 2017; 12(2): e0172165 doi: 10.1371/journal.pone.0172165
8
Sandra Cristina Dias dos Santos, Laura Elisabete Ribeiro Barbosa. Crohn's disease: risk factor for colorectal cancerJournal of Coloproctology 2017; 37(1): 55 doi: 10.1016/j.jcol.2016.06.005
9
Rafael López-Cortés, Raquel Herrero-Hahn, Rosanna De la Rosa-Eduardo, Rafael Montoya-Juárez, María García-Caro, Blanca Marín-Fernández, César Hueso-Montoro. Cultural Adaptation and Validation of the Inflammatory Bowel Disease Disability Index in a Spanish Population and Its Association with Sociodemographic and Clinical FactorsInternational Journal of Environmental Research and Public Health 2019; 16(4): 635 doi: 10.3390/ijerph16040635
10
Marília L. Cravo, Paula A. Ferreira, Patricia Sousa, Paula Moura-Santos, Sónia Velho, Lurdes Tavares, João R. de Deus, Paula Ministro, Paula Peixe, Luis A. Correia, José F. Velosa, Rui F. Maio, Miguel Brito. IL23R polymorphisms influence phenotype and response to therapy in patients with ulcerative colitisEuropean Journal of Gastroenterology & Hepatology 2014; 26(1): 26 doi: 10.1097/MEG.0000000000000004
11
A. C. Moss. Optimizing the use of biological therapy in patients with inflammatory bowel diseaseGastroenterology Report 2015; 3(1): 63 doi: 10.1093/gastro/gou087
12
Michael Christian Sulz, Joel Duetschler, Frank Seibold. Therapiealgorithmen für die Behandlung des Morbus Crohn im klinischen AlltagSchweizer Gastroenterologie 2020; 1(2): 51 doi: 10.1007/s43472-020-00009-9
13
Vivek Chhaya, Sonia Saxena, Elizabeth Cecil, Venkataraman Subramanian, Vasa Curcin, Azeem Majeed, Richard C. Pollok. Emerging trends and risk factors for perianal surgery in Crohn’s diseaseEuropean Journal of Gastroenterology & Hepatology 2016; 28(8): 890 doi: 10.1097/MEG.0000000000000651
14
Joana Torres, Flavio Caprioli, Konstantinos H. Katsanos, Triana Lobatón, Dejan Micic, Marco Zerôncio, Gert Van Assche, James C. Lee, James O. Lindsay, David T. Rubin, Remo Panaccione, Jean-Frédéric Colombel. Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel DiseasesJournal of Crohn's and Colitis 2016; 10(12): 1385 doi: 10.1093/ecco-jcc/jjw116
15
Emily C Oxford, Deanna D Nguyen, Jenny Sauk, Joshua R Korzenik, Vijay Yajnik, Sonia Friedman, Ashwin N Ananthakrishnan. Impact of Coexistent Celiac Disease on Phenotype and Natural History of Inflammatory Bowel DiseasesAmerican Journal of Gastroenterology 2013; 108(7): 1123 doi: 10.1038/ajg.2013.20
16
Yusuf Kayar, Bulent Baran, Asli Cifcibasi Ormeci, Filiz Akyuz, Kadir Demir, Fatih Besisik, Sabahattin Kaymakoglu. Risk factors associated with progression to intestinal complications of Crohn diseaseChinese Medical Journal 2019; 132(20): 2423 doi: 10.1097/CM9.0000000000000489
17
Andreas Stallmach, Luisa Nickel, Thomas Lehmann, Bernd Bokemeyer, Martin Bürger, Dietrich Hüppe, Wolfgang Kruis, Susanna Nikolaus, Jan C Preiss, Andreas Sturm, Niels Teich, Carsten Schmidt. Parameters of a severe disease course in ulcerative colitisWorld Journal of Gastroenterology 2014; 20(35): 12574-12580 doi: 10.3748/wjg.v20.i35.12574
18
Delphine Sterlin, Jehane Fadlallah, Emma Slack, Guy Gorochov. The antibody/microbiota interface in health and diseaseMucosal Immunology 2020; 13(1): 3 doi: 10.1038/s41385-019-0192-y
19
Kouichi Asano, Motohiro Esaki, Junji Umeno, Atsushi Hirano, Yuji Maehata, Tomohiko Moriyama, Shotaro Nakamura, Takayuki Matsumoto, Takanari Kitazono. Contribution of susceptibility variants at FCGR2A and 13q12 to the risk of relapse among Japanese patients with ulcerative colitisJournal of Gastroenterology 2015; 50(11): 1094 doi: 10.1007/s00535-015-1062-3
20
S. Maignant, C. Pélatan, E. Breton, B. Cagnard, E. Chaillou, J.-L. Giniès, G. Le Hénaff, J.-F. Ségura, S. Willot, L. Bridoux, A. Jobert, E. Darviot, N. Delaperrière, D. Lapeyre, E. Carré, I. Grimal, R. Hankard, A.-C. Wagner, M. Balençon, D. Caldari, Y. Tourtelier, A. Dabadie. Connaissances des adolescents atteints de maladie inflammatoire chronique intestinale : résultats d’une enquête transversale multicentriqueArchives de Pédiatrie 2015; 22(5): 468 doi: 10.1016/j.arcped.2015.01.013
21
Antonio Rispo, Anna Testa, Giovanni Domenico De Palma, Sara Donetto, Maria Diaferia, Dario Musto, Olga Nardone, Francesco Maione, Nicola Caporaso, Fabiana Castiglione. Different Profile of Efficacy of Thiopurines in Ulcerative Colitis and Crohnʼs DiseaseInflammatory Bowel Diseases 2015; 21(11): 2570 doi: 10.1097/MIB.0000000000000538
22
Natashia M. Seemann, Sebastian K. King, Abdul Elkadri, Thomas Walters, Joel Fish, Jacob C. Langer. The operative management of children with complex perianal Crohn's diseaseJournal of Pediatric Surgery 2016; 51(12): 1993 doi: 10.1016/j.jpedsurg.2016.09.021
23
Alessandro Armuzzi, Daniela Pugliese. Crohn's Disease and Ulcerative Colitis2017; : 351 doi: 10.1007/978-3-319-33703-6_33
24
Fernando T. Veloso. Clinical predictors of Crohn’s disease courseEuropean Journal of Gastroenterology & Hepatology 2016; 28(10): 1122 doi: 10.1097/MEG.0000000000000698
25
Trinidad Montero-Meléndez, Xavier Llor, Esther García-Planella, Mauro Perretti, Antonio Suárez, Raffaele A. Calogero. Identification of Novel Predictor Classifiers for Inflammatory Bowel Disease by Gene Expression ProfilingPLoS ONE 2013; 8(10): e76235 doi: 10.1371/journal.pone.0076235
26
Jehane Fadlallah, Delphine Sterlin, Claire Fieschi, Christophe Parizot, Karim Dorgham, Hela El Kafsi, Gaëlle Autaa, Pascale Ghillani-Dalbin, Catherine Juste, Patricia Lepage, Marion Malphettes, Lionel Galicier, David Boutboul, Karine Clément, Sébastien André, Florian Marquet, Christophe Tresallet, Alexis Mathian, Makoto Miyara, Eric Oksenhendler, Zahir Amoura, Hans Yssel, Martin Larsen, Guy Gorochov. Synergistic convergence of microbiota-specific systemic IgG and secretory IgAJournal of Allergy and Clinical Immunology 2019; 143(4): 1575 doi: 10.1016/j.jaci.2018.09.036
27
J.C. Andreu-Ballester, I. Catalán-Serra, R. Gil-Borrás, P. Marqués-García, C. García-Ballesteros, F. López Chuliá, C. Cuéllar. Gammadelta T cells as a predictor of surgical relapse of Crohn's diseaseClinics and Research in Hepatology and Gastroenterology 2020; 44(4): 586 doi: 10.1016/j.clinre.2019.11.003
28
Jose C. Gallego, Ana Echarri. Role of magnetic resonance imaging in the management of perianal Crohn’s diseaseInsights into Imaging 2018; 9(1): 47 doi: 10.1007/s13244-017-0579-9
29
Michael J Mintz, Ashwin N Ananthakrishnan. Phenotype and Natural History of Inflammatory Bowel Disease in Patients With Concomitant Eosinophilic EsophagitisInflammatory Bowel Diseases 2020;  doi: 10.1093/ibd/izaa094
30
Mimi C. Tan, Hashem B. El-Serag, Jason K. Hou. Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel DiseaseDigestive Diseases and Sciences 2017; 62(3): 607 doi: 10.1007/s10620-016-4414-9
31
A Hillary Steinhart, Remo Panaccione, Laura Targownik, Brian Bressler, Reena Khanna, John K Marshall, Waqqas Afif, Charles N Bernstein, Alain Bitton, Mark Borgaonkar, Usha Chauhan, Brendan Halloran, Jennifer Jones, Erin Kennedy, Grigorios I Leontiadis, Edward V Loftus, Jonathan Meddings, Paul Moayyedi, Sanjay Murthy, Sophie Plamondon, Greg Rosenfeld, David Schwartz, Cynthia H Seow, Chadwick Williams. Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn’s Disease: The Toronto ConsensusInflammatory Bowel Diseases 2019; 25(1): 1 doi: 10.1093/ibd/izy247
32
Fabiola Trejo‑Vazquez, Idalia Garza‑Veloz, Gabriela Villela‑Ramirez, Yolanda Ortiz‑Castro, Panfilo Mauricio‑Saucedo, Edith Cardenas‑Vargas, Mariana Diaz‑Baez, Miguel Cid‑Baez, Rodrigo Casta�eda‑Miranda, Jose Ortiz‑Rodriguez, Luis Solis‑Sanchez, Margarita Martinez‑Fierro. Positive association between leptin serum levels and disease activity on endoscopy in inflammatory bowel disease: A case-control studyExperimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.5835
33
Sung Chul Park, Yoon Tae Jeen. Genetic Studies of Inflammatory Bowel Disease-Focusing on Asian PatientsCells 2019; 8(5): 404 doi: 10.3390/cells8050404
34
Jörg Mahlich, Katsuyoshi Matsuoka, Rosarin Sruamsiri. Biologic treatment of Japanese patients with inflammatory bowel diseaseBMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0892-x
35
Inger Camilla Solberg, Marte Lie Høivik, Milada Cvancarova, Bjørn Moum. Risk matrix model for prediction of colectomy in a population-based study of ulcerative colitis patients (the IBSEN study)Scandinavian Journal of Gastroenterology 2015; 50(12): 1456 doi: 10.3109/00365521.2015.1064991
36
Carla Carnovale, Anna Maffioli, Gloria Zaffaroni, Faizan Mazhar, Vera Battini, Giulia Mosini, Marco Pozzi, Sonia Radice, Emilio Clementi, Piergiorgio Danelli. Efficacy of Tumour Necrosis Factor-alpha therapy in paediatric Crohn’s disease patients with perianal lesions: a systematic reviewExpert Opinion on Biological Therapy 2020; 20(3): 239 doi: 10.1080/14712598.2020.1718096
37
Nai-Ying Shen, Jian-Bin Bi, Jing-Yao Zhang, Si-Min Zhang, Jing-Xian Gu, Kai Qu, Chang Liu. Hydrogen-rich water protects against inflammatory bowel disease in mice by inhibiting endoplasmic reticulum stress and promoting heme oxygenase-1 expressionWorld Journal of Gastroenterology 2017; 23(8): 1375-1386 doi: 10.3748/wjg.v23.i8.1375
38
David B. Sachar. Role of Biomarkers in the Study and Management of Inflammatory Bowel DiseaseInflammatory Bowel Diseases 2014; 20(12): 2511 doi: 10.1097/MIB.0000000000000135
39
Naoto Saigusa, Tadashi Yokoyama, Masaru Shinozaki, Ryoji Miyahara, Tsuyoshi Konishi, Toshio Nakamura, Yasuhisa Yokoyama. Anorectal fistula is an early manifestation of Crohn’s disease that occurs before bowel lesions advance: a study of 11 casesClinical Journal of Gastroenterology 2013; 6(4): 309 doi: 10.1007/s12328-013-0404-z
40
Remo Panaccione, A Hillary Steinhart, Brian Bressler, Reena Khanna, John K Marshall, Laura Targownik, Waqqas Afif, Alain Bitton, Mark Borgaonkar, Usha Chauhan, Brendan Halloran, Jennifer Jones, Erin Kennedy, Grigorios I Leontiadis, Edward V Loftus, Jonathan Meddings, Paul Moayyedi, Sanjay Murthy, Sophie Plamondon, Greg Rosenfeld, David Schwartz, Cynthia H Seow, Chadwick Williams, Charles N Bernstein. Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn’s DiseaseJournal of the Canadian Association of Gastroenterology 2019; 2(3): e1 doi: 10.1093/jcag/gwz019
41
Cláudia Camila Dias, Pedro Pereira Rodrigues, Rosa Coelho, Paula Moura Santos, Samuel Fernandes, Paula Lago, Cidalina Caetano, Ângela Rodrigues, Francisco Portela, Ana Oliveira, Paula Ministro, Eugénia Cancela, Ana Isabel Vieira, Rita Barosa, José Cotter, Pedro Carvalho, Isabelle Cremers, Daniel Trabulo, Paulo Caldeira, Artur Antunes, Isadora Rosa, Joana Moleiro, Paula Peixe, Rita Herculano, Raquel Gonçalves, Bruno Gonçalves, Helena Tavares Sousa, Luís Contente, Henrique Morna, Susana Lopes, Fernando Magro. Development and Validation of Risk Matrices for Crohn’s Disease Outcomes in Patients Who Underwent Early Therapeutic InterventionsJournal of Crohn's and Colitis 2016; : jjw171 doi: 10.1093/ecco-jcc/jjw171
42
Maša Umićević Mirkov, Bram Verstockt, Isabelle Cleynen. Genetics of inflammatory bowel disease: beyond NOD2The Lancet Gastroenterology & Hepatology 2017; 2(3): 224 doi: 10.1016/S2468-1253(16)30111-X
43
Ren Mao, Yun Qiu, Bai-Li Chen, Sheng-Hong Zhang, Rui Feng, Yao He, Zhi- Rong Zeng, Shomron Ben-Horin, Min-Hu Chen. Factors associated with the achievement of mucosal healing in Crohn’s disease: the benefit of endoscopic monitoring in treating to targetTherapeutic Advances in Gastroenterology 2017; 10(6): 453 doi: 10.1177/1756283X17698089
44
A Hillary Steinhart, Remo Panaccione, Laura Targownik, Brian Bressler, Reena Khanna, John K Marshall, Waqqas Afif, Charles N Bernstein, Alain Bitton, Mark Borgaonkar, Usha Chauhan, Brendan Halloran, Jennifer Jones, Erin Kennedy, Grigorios I Leontiadis, Edward V Loftus, Jonathan Meddings, Paul Moayyedi, Sanjay Murthy, Sophie Plamondon, Greg Rosenfeld, David Schwartz, Cynthia H Seow, Chadwick Williams. Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn’s Disease: The Toronto ConsensusJournal of the Canadian Association of Gastroenterology 2018; 1(4): 141 doi: 10.1093/jcag/gwy047
45
Ho-Su Lee, Isabelle Cleynen. Molecular Profiling of Inflammatory Bowel Disease: Is It Ready for Use in Clinical Decision-Making?Cells 2019; 8(6): 535 doi: 10.3390/cells8060535
46
Sudarshan Paramsothy, Adam K. Rosenstein, Saurabh Mehandru, Jean-Frederic Colombel. The current state of the art for biological therapies and new small molecules in inflammatory bowel diseaseMucosal Immunology 2018; 11(6): 1558 doi: 10.1038/s41385-018-0050-3
47
Marta Sobczak, Piotr K. Zakrzewski, Adam I. Cygankiewicz, Anna Mokrowiecka, Chunqiu Chen, Maciej Sałaga, Ewa Małecka-Panas, Radzisław Kordek, Wanda M. Krajewska, Jakub Fichna. Anti-inflammatory action of a novel orally available peptide 317 in mouse models of inflammatory bowel diseasesPharmacological Reports 2014; 66(5): 741 doi: 10.1016/j.pharep.2014.03.007
48
Remo Panaccione, A. Hillary Steinhart, Brian Bressler, Reena Khanna, John K. Marshall, Laura Targownik, Waqqas Afif, Alain Bitton, Mark Borgaonkar, Usha Chauhan, Brendan Halloran, Jennifer Jones, Erin Kennedy, Grigorios I. Leontiadis, Edward V. Loftus, Jonathan Meddings, Paul Moayyedi, Sanjay Murthy, Sophie Plamondon, Greg Rosenfeld, David Schwartz, Cynthia H. Seow, Chadwick Williams, Charles N. Bernstein. Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn’s DiseaseClinical Gastroenterology and Hepatology 2019; 17(9): 1680 doi: 10.1016/j.cgh.2019.02.043
49
Fernando Magro, Cláudia Camila Dias, Francisco Portela, Mário Miranda, Samuel Fernandes, Sonia Bernardo, Paula Ministro, Paula Lago, Isadora Rosa, Inês Pita, Luis Correia, Pedro Pereira Rodrigues. Development and Validation of Risk Matrices Concerning Ulcerative Colitis Outcomes—Bayesian Network AnalysisJournal of Crohn's and Colitis 2019; 13(4): 401 doi: 10.1093/ecco-jcc/jjy168